Buspar and Dilantin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Buspar (buspirone hydrochloride) and Dilantin (phenytoin sodium). Common drug interactions include blood glucose increased among females and convulsion among males.
The phase IV clinical study analyzes what interactions people have when they take Buspar and Dilantin. It is created by eHealthMe based on reports of 123 people who take the same drugs from the FDA, and is updated regularly.
What is Buspar?
Buspar has active ingredients of buspirone hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 20,463 Buspar users. Check the latest studies of Buspar.
What is Dilantin?
Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
123 people who take Buspar and Dilantin together, and have interactions are studied.
What are the common drug interactions of Buspar and Dilantin, by gender? *
What are the common drug interactions of Buspar and Dilantin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Buspar and Dilantin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Buspar and Dilantin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Buspar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dilantin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Buspar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dilantin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on buspirone hydrochloride and phenytoin sodium (the active ingredients of Buspar and Dilantin, respectively), and Buspar and Dilantin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Afinitor and Mesna drug interactions for women aged 20-29 - 16 seconds ago
- Celexa and Viibryd drug interactions for women aged 40-49 - 27 seconds ago
- How effective is Lorazepam for Insomnia? - a minute ago
- Cephalexin and Liver Enlargement for Men aged 60+ - a minute ago
- Cephalexin and Hepatosplenomegaly for Men aged 60+ - a minute ago
- Cephalexin and Enlarged Liver for Men aged 60+ - a minute ago
- Cephalexin and Hepatomegaly for Men aged 60+ - a minute ago
- Could Xarelto cause Medical Device Complication? - a minute ago
- Could Lyrica cause Alcohol Poisoning? - a minute ago
- Clonidine and Gastroesophageal Reflux Disease for Women aged 30-39 - 2 minutes ago